|
FY2022
12 months to Oct 31, 2022
|
|
|---|---|
| Cash flows from operating activities | |
| Net loss | |
| Items not affecting cash: | |
| Amortization and depreciation | |
| Share-based compensation | |
| Consulting | |
| Loss (gain) on revaluation of warrant derivative | |
| Interest expense | |
| Unrealized foreign exchange | |
| Financing costs | |
| Changes in non-cash working capital | |
| Accounts and other receivables | |
| Inventory | |
| Term deposit | |
| Prepaid expenses and deposits | |
| Accounts payable and accrued liabilities | |
| Deferred revenue | |
| Net cash flows used in operating activities | |
| Cash flows from investing activities | |
| Purchase of property and equipment | |
| Net cash flows used in investing activities | |
| Cash flows from financing activities | |
| Proceeds from promissory notes net of costs | |
| Repayment of promissory notes | |
| Proceeds from equity financings | |
| Broker warrants | |
| Repayment of loans | |
| Net cash flows provided by financing activities | |
| Change in cash | |
| Cash | |
| Beginning of year | |
| End of year | |
| Supplemental cash flow disclosure | |
| Interest |
Loading...
